Metagenomi, Inc. Common Stock
MGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $54,992 | $50,346 | $133,904 |
| - Cash | $32,773 | $26,850 | $29,195 | $27,386 |
| + Debt | $36,092 | $42,990 | $44,437 | $45,778 |
| Enterprise Value | – | $71,132 | $65,588 | $152,296 |
| Revenue | $8,659 | $8,513 | $4,127 | $9,614 |
| % Growth | 1.7% | 106.3% | -57.1% | – |
| Gross Profit | $7,335 | -$13,994 | $4,127 | $9,614 |
| % Margin | 84.7% | -164.4% | 100% | 100% |
| EBITDA | -$19,303 | -$19,652 | -$26,462 | -$19,162 |
| % Margin | -222.9% | -230.8% | -641.2% | -199.3% |
| Net Income | -$20,393 | -$19,908 | -$25,039 | -$23,398 |
| % Margin | -235.5% | -233.9% | -606.7% | -243.4% |
| EPS Diluted | -0.55 | -0.54 | -0.68 | -0.63 |
| % Growth | -1.9% | 20.6% | -7.9% | – |
| Operating Cash Flow | -$21,253 | -$21,251 | -$22,842 | -$26,276 |
| Capital Expenditures | -$74 | -$127 | -$288 | -$334 |
| Free Cash Flow | -$21,327 | -$21,378 | -$23,130 | -$26,610 |